GlassScriptPhysician profile
Barry P Levin
NPI 1851449334
$28,026.98
in general payments reported to CMS, 2019-2025
9 companies · $374 in 2025
The $374 reported for 2025 was more than what 78% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $16.77 · 2021: $187 · 2022: $3,031 · 2023: $29.53 · 2024: $12K · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,935 · Honoraria: $5,000 · Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,934.80 |
| Honoraria | $5,000.00 |
| Food and Beverage | $571.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Implants North America INC | $27,397.08 | 2019-2024 | Inverta |
| Zimvie INC. | $223.89 | 2025 | |
| Salvin Dental Specialties, INC. | $157.29 | 2019 | |
| Arteriocyte Medical Systems, INC. | $150.55 | 2025 | Magellan |
| Sonendo INC | $29.53 | 2023 | Gentlewave G4 Console |
| Dentsply Ih INC. | $28.71 | 2019 | |
| Dentsply Sirona INC | $14.44 | 2022 | |
| Colgate Oral Pharmaceuticals, INC. | $14.34 | 2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.